Ladenburg Thalmann Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 5184 |
|
|
2019
Q3 | $1K | Sell |
12
-27
| -69% | -$2.25K | ﹤0.01% | 5099 |
|
|
2019
Q2 | $3K | Buy |
39
+12
| +44% | +$923 | ﹤0.01% | 4862 |
|
|
2019
Q1 | $3K | Sell |
27
-47
| -64% | -$5.22K | ﹤0.01% | 4816 |
|
|
2018
Q4 | $5K | Buy |
+74
| New | +$5K | ﹤0.01% | 4579 |
|
|
2016
Q3 | – | Sell |
-849
| Closed | -$18K | – | 4796 |
|
|
2016
Q2 | $18K | Sell |
849
-43
| -5% | -$912 | ﹤0.01% | 3407 |
|
|
2016
Q1 | $26K | Buy |
892
+162
| +22% | +$4.72K | ﹤0.01% | 3060 |
|
|
2015
Q4 | $24K | Sell |
730
-200
| -22% | -$6.58K | ﹤0.01% | 3083 |
|
|
2015
Q3 | $33K | Buy |
930
+17
| +2% | +$603 | ﹤0.01% | 2750 |
|
|
2015
Q2 | $41K | Hold |
913
| – | – | ﹤0.01% | 2722 |
|
|
2015
Q1 | $28K | Sell |
913
-9,185
| -91% | -$282K | ﹤0.01% | 2967 |
|
|
2014
Q4 | $513K | Buy |
10,098
+9,833
| +3,711% | +$500K | 0.01% | 911 |
|
|
2014
Q3 | $10K | Buy |
+265
| New | +$10K | ﹤0.01% | 3092 |
|